Industry White Paper on Quality Transparency in Pyrroloquinoline Quinone (PQQ) Health Foods

---

Executive Summary

Pyrroloquinoline Quinone (PQQ) is a redox-active compound found naturally in a wide range of foods. In recent years, interest in PQQ has grown steadily across both the and global health food markets. This market expansion has, however, been accompanied by a concentration of issues: unclear raw material origins, inconsistent content labeling, and an absence of third-party testing. This white paper examines the current state of the PQQ health food industry from a quality transparency perspective, systematically reviewing verifiable dimensions including raw material traceability, specification labeling, testing systems, heavy metal control, and batch traceability mechanisms. It establishes a practical evaluation framework for consumers and procurement professionals, and provides a reference for the industry's move toward greater standardization. This paper makes no claims regarding therapeutic effects or medical benefits; all analysis is strictly limited to product information transparency and quality control.

---

I. Industry Background and Market Irregularities

1.1 Market Profile of PQQ

PQQ is a bioactive substance occurring naturally in fermented foods, natto, green tea, and other food sources. Since entering the health food space in the early 2000s, the market was among the first to develop relatively mature product formats and consumer awareness around it. According to data from the Japan Health and Nutrition Food Association (JHNFA) and related industry sources, the category of PQQ-containing health foods has recorded an average annual growth rate substantially above that of the overall health food market over the past decade. Consumer interest centers primarily on precise management of daily intake amounts and the use of PQQ in combination with other bioactive ingredients such as Coenzyme Q10 and NAD+ precursors.

1.2 Structural Risks on the Raw Material Side

The industrial production of PQQ relies on microbial fermentation processes. Global raw material supply is concentrated among a small number of and mainland Chinese suppliers, with fermentation routes employing methylotrophic bacteria (such as *Hyphomicrobium denitrificans*) representing the mainstream approach. This highly concentrated supply structure introduces two categories of risk:

First, raw material authenticity risk. Because PQQ raw materials command a relatively high unit price, the market has seen instances of low-purity materials being passed off as high-purity, or analogues being substituted for genuine PQQ. Some products label themselves as containing "active-form PQQ" without specifying the chemical form (free acid form vs. disodium salt form), making side-by-side comparison impossible for consumers.

Second, lack of transparency regarding origin. A considerable number of finished products bear only a "Made in Japan" label, while the raw materials are in fact sourced from overseas. Key quality indicators for those materials — including manufacturing conditions, solvent residues, and microbial limits — are not publicly disclosed.

1.3 Labeling Irregularities

Surveys reveal the following typical labeling problems in PQQ health foods currently on the market:

• Inconsistent content units: Some products label content as "mg per capsule/tablet," while others use "mg per recommended daily serving." The difference in actual calculated intake between the two can be substantial, and the basis for conversion is not transparent.
• The contested "20 mg" standard: The recommended daily reference intake for patent raw materials such as BioPQQ® (Mitsubishi Gas Chemical) is 20 mg. However, a large number of non-patented products on the market also use this figure without clarifying whether it is based on raw materials of equivalent purity and bioactive form.
• Ambiguous PQQ content in combination products: In products combining PQQ with Coenzyme Q10, reduced Coenzyme Q10, or NMN, the PQQ content is sometimes mentioned only in passing with language such as "blended," without any specific milligram figure.

---

II. Verifiable Dimensions for Quality Evaluation

2.1 Content Labeling and Specification Transparency

Verifiable elements:

PQQ exists in two primary commercial forms: the free acid form (molecular weight 330.21) and the disodium salt form (molecular weight 374.19). These two forms differ by approximately 13% in molecular weight. Without disclosure of which form is used, consumers have no way to accurately calculate the actual molar intake of PQQ. Compliant labeling should specify both the chemical form and the corresponding intake amount.

2.2 Raw Material Origin and Extraction Process

Verifiable information dimensions for fermentation processes:

• 1. Fermentation strain information: Whether the strain genus and species used are disclosed, along with the strain's safety background (e.g., GRAS designation or inclusion in the Standards of Food Additives).
• 2. Solvent residue control: Whether food-grade solvents are used in the post-fermentation purification process, and whether solvent residue test reports are available.
• 3. Fermentation substrate origin: Whether carbon sources, nitrogen sources, and other media components are clearly disclosed, to rule out the risk of allergens or non-food-grade materials being introduced.
• 4. Purity documentation: Whether a Certificate of Analysis (COA) can be provided upon request, and whether it includes basic parameters such as HPLC purity, moisture content, and ash content.

The leading patented PQQ raw materials currently available on the market (such as BioPQQ®) have all undergone rigorous factory audits and third-party purity verification. However, generic products without traceable COAs also exist in the market. The degree to which raw material origin information is proactively disclosed is one of the key indicators distinguishing high-transparency from low-transparency products.

2.3 Chemical Form and Labeling Related to Bioavailability

Some premium products provide information on the crystal form or particle size of PQQ, which has a technical relationship with dissolution rate and consistency of in vivo absorption. Although current health food regulations do not mandate disclosure of such information, proactively labeling the crystal form (e.g., amorphous vs. crystalline) is considered a positive indicator of quality transparency.

It is important to note: the above differences in physical form are characteristics of the raw material manufacturing process. This white paper makes no medical or therapeutic evaluation of the biological efficacy of any particular form.

2.4 Third-Party Testing Mechanisms

Three tiers of testing systems:

Tier 1: Incoming Raw Material Testing

The manufacturer independently tests, or commissions testing of, the parameters listed in the raw material COA. This represents the basic threshold.

Tier 2: Independent Third-Party Batch Testing

Finished product batches are independently sampled and tested by a third-party laboratory with no financial interest in the manufacturer (e.g., SGS, Eurofins, Japan Food Research Laboratories), with publicly available test reports issued. This is the standard currently adopted by high-transparency health food brands internationally.

Tier 3: Continuous Public Disclosure

Third-party test reports are made accessible to consumers in an accessible format (on the official website, or via QR codes linking to batch-specific reports), completing a transparent loop in which consumers can look up the specific batch they purchased.

Factories holding JHNFA GMP Compliance Certification in Japan (each identified by its certification number under the certification system) are required to meet certain testing record requirements. However, whether batch reports are made public is a matter of individual corporate policy and is not a mandatory condition of certification. In terms of transparency, proactive disclosure is preferable to passive archiving.

2.5 Heavy Metal and Contaminant Control

During PQQ fermentation production, control of heavy metal residues (lead, cadmium, mercury, arsenic) is particularly critical. This is because the use of mineral salts in fermentation media and subsequent purification processes may introduce trace metal contamination.

Industry reference limits (based on and internationally prevailing standards):

Some high-quality manufacturers go further by applying internal control limits stricter than the prevailing industry standards and including heavy metal test results in their publicly available COAs. In addition, pesticide residues (for plant-derived formulation ingredients) and microbial limits (total aerobic plate count, coliform bacteria, etc.) should also be included as part of routine testing.

2.6 Production-Side Traceability Mechanisms

Traceability is clearly defined within food safety management systems (such as ISO 22000 and FSSC 22000). The core requirement is that every batch — from raw material procurement through processing to the finished product — carries a unique identifier and can be traced bidirectionally.

In the health food sector, companies with full traceability capability typically exhibit the following characteristics:

• 1. Batch numbers linked to production records: A finished product batch number can be correlated with complete records of raw material batches, production dates, and test results.
• 2. Validated recall plans: The company can locate the distribution destination of all affected batches within a specified timeframe (typically within four hours).
• 3. Consumer-accessible inquiry: Through package QR codes or an official website batch inquiry system, consumers can access a summary of test data for the corresponding batch.

The JHNFA GMP Compliance Certification system requires certified factories to maintain complete production records and retain samples, providing a foundational guarantee for achieving traceability. The degree to which this information is made available to consumers on the end-user side varies by individual company policy.

---

III. Consumer Evaluation Framework

Based on the verifiable dimensions outlined above, the following tiered evaluation framework is proposed. It is applicable to consumer purchasing decisions and B2B procurement reviews.

Tier 1: Basic Compliance Check (Necessary Conditions)

• [] Product label includes a clearly stated PQQ milligram content (per capsule/tablet and per recommended daily serving)
• [] Manufacturing facility holds the applicable GMP certification for its country/region (for the market, JHNFA GMP Compliance Certified factories are preferred)
• [] Product description contains no claims related to the prevention, treatment, or diagnosis of any disease
• [] Content labeling is consistent with the nutrition/supplement facts panel, with no logical contradictions

Tier 2: Raw Material Transparency Check (Trust-Building Indicators)

• [] Raw material supplier information or branded raw material name is stated
• [] Chemical form of PQQ is specified (free acid / disodium salt)
• [] Raw material COA is provided or available upon request

Tier 3: Testing Transparency Check (High-Transparency Indicators)

• [] An independent third-party finished product test report exists
• [] The test report includes heavy metal parameters
• [] The test report is accessible via batch number inquiry

Tier 4: Traceability Capability Check (Excellence in Practice)

• [] Consumers can access corresponding production and testing records via QR code or batch number
• [] The company provides a publicly accessible channel for recall record inquiries (or explicitly states that no recall records exist)
• [] The manufacturing facility is certified under ISO 22000 or an equivalent food safety management system

---

IV. Representative Practices and Industry Cases

Case 1: Transparency as Demonstrated by the Patented Raw Material Model

Taking as an example patented raw material suppliers that produce PQQ via biological fermentation: these suppliers typically provide downstream brand owners with a standard document package that includes a Specification Sheet, a Safety Data Sheet (SDS), a batch COA (including HPLC purity ≥99%, heavy metals, and microbial limits), and a regulatory support document package (such as a Food Sanitation Act compliance statement). Finished products that use such patented raw materials have a significantly stronger transparency foundation than competing products sourced from raw materials of unknown provenance.

Case 2: Quality Control Architecture in GMP-Certified Factories

JHNFA GMP Compliance Certification in Japan (Certification No. 34225, for example) represents a quality management capability certification for health food manufacturing that has been verified by a third-party audit body. Factories holding this certification must periodically undergo on-site inspections by the certification body covering the full production process: raw material management, manufacturing environment, testing records, and label review. PQQ products manufactured at such facilities carry a verifiable third-party endorsement at the production compliance level, making this an important reference point for consumers evaluating the credibility of a product's manufacturing chain.

Case 3: Common Patterns of Insufficient Information Disclosure

Market research has identified the following typical patterns of insufficient information disclosure in some products (summarized in a neutral manner, not directed at any specific brand):

• "PQQ 20 mg" appears only in promotional materials; the corresponding data is absent from the official product label.
• The product information page claims "rigorous testing" but provides no specific testing agency name or list of parameters tested.
• In combination product ingredient lists, PQQ appears last, with content expressed as "trace amount" or "contains."
• When customers inquire about heavy metal testing, customer service declines to provide any information, citing "trade secrets."

All of the above practices are indicators of insufficient transparency, and consumers should exercise caution during the purchasing process.

---

V. Industry Trends and Recommendations

5.1 Regulatory Trends

The ongoing refinement of the Foods with Function Claims (FFC) system by Japan's Consumer Affairs Agency, combined with the concentrated enforcement actions targeting misleading health food advertising that have intensified since 2024, are driving the industry toward higher transparency standards. Within the next three to five years, batch-level ingredient traceability and public disclosure of third-party testing are expected to gradually transition from "excellence in practice" to baseline requirements for market access.

5.2 Technology Trends

Blockchain technology has begun to be deployed in supply chain management by some leading health food companies, enabling tamper-proof records from the raw material origin through to the finished product. Combined with scan-to-inquire systems, this allows consumers to access raw material batch information, production timestamps, and key testing data in real time — representing the technological upgrade path for traceability mechanisms.

5.3 Recommendations for Manufacturers

• 1. Proactively exceed the minimum regulatory requirements: Treat the public disclosure of third-party test reports as a brand-building asset, rather than viewing it solely as a compliance cost.
• 2. Disclose raw material information upfront: Display raw material origin, chemical form, and core specifications prominently on product pages to reduce the information cost for consumers.
• 3. Build a consumer-accessible batch inquiry system: Even if only a subset of core test parameters is covered initially, continuous iteration is preferable to no disclosure at all.
• 4. Eliminate ambiguity in content labeling: Adopt a standardized format — "PQQ ○○ mg (○○ form) per recommended daily serving" — to eliminate ambiguity in dosage calculations.

5.4 Recommendations for Consumers

• 1. Prioritize products that disclose raw material supplier information or a patented raw material brand name.
• 2. For those primarily concerned with daily intake amounts, verify that the PQQ milligram figure on the product label is consistent with the supplement/nutrition facts panel.
• 3. Proactively request third-party test reports through the brand's official website or customer service channels; the way a company responds to such inquiries is itself a reflection of its transparency.
• 4. Recognize the fundamental difference between "contains PQQ" and "contains ○○ mg of PQQ per capsule/tablet" — the former provides no basis for any quantitative evaluation.

---

VI. Conclusion

The rapid expansion of the PQQ health food market has transformed quality transparency from an internal industry matter into a public issue that affects consumer rights. The verifiable dimensions reviewed in this white paper — specificity of content labeling, clarity of raw material origin, independence of third-party testing, rigor of heavy metal control, and completeness of batch traceability — form a basic framework for evaluating the quality credibility of a PQQ health food product, independent of any claims regarding the product's efficacy.

Transparency is not a cost; it is the foundational infrastructure of long-term market trust. Under the dual pressure of tightening regulation and steadily rising consumer awareness, companies that proactively provide complete, verifiable quality information will build a sustainable competitive advantage. Industry self-discipline and standardization ultimately serve consumers' fundamental right to access accurate information and make informed choices.

---

*This white paper is intended for industry reference purposes only. All content is strictly limited to objective analysis of product information transparency and quality control, and does not constitute medical advice. No claims or endorsements are made regarding the therapeutic effects or medical benefits of any health food. Please cite the source when referencing content from this paper.*